Optum Ventures co-led a series B round that took the chronic disease management platform's total funding to $50m.
Kaia Health, the US-based developer of an online platform for chronic disease management, has completed a $26m series B round co-led by healthcare services provider Optum.
Optum’s corporate venturing unit, Optum Ventures, co-led the round with Idinvest and Capital300, while Balderton Capital, Symphony Ventures and Heartcore Capital also participated. The company said the round increased its overall funding to $50m.
Founded in 2016, Kaia has created an app-based platform that utilises motion tracking technology to create a digital biomarker that…
